Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates AKTX Bearish with a Setup Score of 41, net conviction 39, actionability 44. How the Setup Score works →
Total Setup Score
41
Directional Bias
Bearish
Net Conviction
39
Actionability
44 (in range)
Key signals behind this score
40wk Downtrend — falling+below (sma 12.57 vs px 11.01)
Fresh Breakdown — 40wk recapture 1w
80wk Downtrend — falling+below (sma 28.39 vs px 11.01)
200wk Downtrend — falling+below (sma 117 vs px 11.01)
Seasonal Headwind — october med -13.8% (mag 2/3) · posClose 25.00% (rel 2/3) · n12 ×0.5 = 5.5
About Akari Therapeutics PLC
Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bl… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: September 21, 2015
Headquarters: 401 East Jackson Street, Tampa, FL, United States, 33602
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$12.36
Near-term / short-term trend
Weekly
40-Week SMA
$12.57
Medium-term trend
Weekly
80-Week SMA
$28.39
Cyclical trend (business cycle)
Weekly
200-Week SMA
$116.78
Secular trend (multi-year)
Monthly
10-Month SMA
$12.81
Near-term monthly trend
Monthly
20-Month SMA
$28.76
Medium-term monthly trend
Monthly
40-Month SMA
$73.57
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Akari Therapeutics PLC
(AKTX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.